Elevidys® (delandistrogene moxeparvovec-rokl)
for Duchenne Muscular Dystrophy

Elevidys (delandistrogene moxeparvovec-rokl) is a gene therapy for Duchenne muscular dystrophy (DMD) designed to strengthen muscles by enabling the production of micro-dystrophin. Using a vector to deliver a functional dystrophin gene, Elevidys helps protect muscle cells, slow degeneration, and maintain muscle strength over time.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Duchenne Muscular Dystrophy